Market Place
Sourcing Support
Mythic Therapeutics Presents Efficacy Data for MYTX-011 at ASCO
31 May 2025 //
BUSINESSWIRE
Mythic Therapeutics to Present Efficacy Data from KisMET-01 Study
22 May 2025 //
BUSINESSWIRE
Mythic Therapeutics to Present Updated Data at 2025 ASCO Meeting
01 May 2025 //
BUSINESSWIRE
Mythic Therapeutics Shows MYTX-011 Efficacy at AACR Meeting
28 Apr 2025 //
BUSINESSWIRE
Mythic`s MYTX-011 Initial Dose Escalation Data At ASCO 2024
03 Jun 2024 //
BUSINESSWIRE
Mythic Mytx-011 Kis Met Phase 1: Asco 2024 Annual Meeting Data
23 May 2024 //
BUSINESSWIRE
Mythic Therapeutics MYTX-011 Preclinical Data Published
30 Apr 2024 //
BUSINESSWIRE
Mythic Therapeutics Presents Preclinical Data on MYTX-011 at the AACR
08 Apr 2024 //
BUSINESSWIRE
Mythic Therapeutics Appoints George Eliades, Ph.D., as President and CEO
28 Mar 2024 //
BUSINESSWIRE
ADC startup Mythic recruits Jazz exec to lead company; Dyne’s CEO shuffle
28 Mar 2024 //
ENDPTS
Mythic Therapeutics Receives FDA Fast Track Designation for MYTX-011
26 Sep 2023 //
BUSINESSWIRE
Mythic Therapeutics to Present New Preclinical Data on MYTX-011
19 Sep 2023 //
BUSINESSWIRE
Mythic Presents Preclinical Data on Inveg cMET-Targeting (ADC) MYTX-011
18 Apr 2023 //
BUSINESSWIRE
Mythic Announces First Subject Dosed in Phase 1 KisMET-01 Trial of MYTX-011
04 Apr 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.